Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Chem Biol ; 25(9): 1059-1066.e4, 2018 09 20.
Article in English | MEDLINE | ID: mdl-29887265

ABSTRACT

In response to environmental and other stresses, the σ54 subunit of bacterial RNA polymerase (RNAP) controls expression of several genes that play a significant role in the virulence of both plant and animal pathogens. Recruitment of σ54 to RNAP initiates promoter-specific transcription via the double-stranded DNA denaturation mechanism of the cofactor. The RpoN box, a recognition helix found in the C-terminal region of σ54, has been identified as the component necessary for major groove insertion at the -24 position of the promoter. We employed the hydrocarbon stapled peptide methodology to design and synthesize stapled σ54 peptides capable of penetrating Gram-negative bacteria, binding the σ54 promoter, and blocking the interaction between endogenous σ54 and its target DNA sequence, thereby reducing transcription and activation of σ54 response genes.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Gene Expression Regulation, Bacterial/drug effects , Gram-Negative Bacteria/drug effects , Peptides/chemistry , Peptides/pharmacology , Transcriptional Activation/drug effects , Drug Design , Genes, Bacterial/drug effects , Gram-Negative Bacteria/genetics , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Humans , Models, Molecular , Promoter Regions, Genetic/drug effects
2.
Cell Rep ; 23(4): 1192-1204, 2018 04 24.
Article in English | MEDLINE | ID: mdl-29694895

ABSTRACT

The linear ubiquitin chain assembly complex (LUBAC) participates in inflammatory and oncogenic signaling by conjugating linear ubiquitin chains to target proteins. LUBAC consists of the catalytic HOIP subunit and two accessory subunits, HOIL-1L and SHARPIN. Interactions between the ubiquitin-associated (UBA) domains of HOIP and the ubiquitin-like (UBL) domains of two accessory subunits are involved in LUBAC stabilization, but the precise molecular mechanisms underlying the formation of stable trimeric LUBAC remain elusive. We solved the co-crystal structure of the binding regions of the trimeric LUBAC complex and found that LUBAC-tethering motifs (LTMs) located N terminally to the UBL domains of HOIL-1L and SHARPIN heterodimerize and fold into a single globular domain. This interaction is resistant to dissociation and plays a critical role in stabilizing trimeric LUBAC. Inhibition of LTM-mediated HOIL-1L/SHARPIN dimerization profoundly attenuated the function of LUBAC, suggesting LTM as a superior target of LUBAC destabilization for anticancer therapeutics.


Subject(s)
Carrier Proteins/chemistry , Multiprotein Complexes/chemistry , Polyubiquitin/chemistry , Amino Acid Motifs , Animals , Carrier Proteins/metabolism , Crystallography, X-Ray , Intracellular Signaling Peptides and Proteins , Mice , Multiprotein Complexes/metabolism , Polyubiquitin/metabolism , Protein Domains , Protein Structure, Quaternary
3.
Bioorg Med Chem ; 26(6): 1179-1188, 2018 03 15.
Article in English | MEDLINE | ID: mdl-29246782

ABSTRACT

Linear ubiquitylation, in which ubiquitin units are covalently linked through N- and C-terminal amino acids, is a unique cellular signaling mechanism. This process is controlled by a single E3 ubiquitin ligase, the linear ubiquitin chain assembly complex (LUBAC), which is composed of three proteins - HOIL-1L, HOIP and SHARPIN. LUBAC is involved in the activation of the canonical NF-κB pathway and has been linked to NF-κB dependent malignancies. In this work, we present HOIP-based stapled alpha-helical peptides designed to inhibit LUBAC through the disruption of the HOIL-1L-HOIP interaction and loss of the functional complex. We find our HOIP peptides to be active LUBAC ubiquitylation inhibitors in vitro, though through interaction with HOIP rather than HOIL. Active peptides were shown to have inhibitory effects on cell viability, reduced NF-κB activity and decreased production of NF-κB related gene products. This work further demonstrates the potential of LUBAC as a therapeutic target and of the use of stapled peptides as inhibitors of protein-protein interactions.


Subject(s)
Peptides/metabolism , Ubiquitin-Protein Ligases/metabolism , Amino Acid Sequence , Cell Line, Tumor , Cell Survival/drug effects , Humans , NF-kappa B/metabolism , Peptides/chemistry , Peptides/pharmacology , Protein Binding , Protein Interaction Domains and Motifs/drug effects , Protein Structure, Secondary , Signal Transduction/drug effects , Ubiquitin-Protein Ligases/antagonists & inhibitors , Ubiquitination , Ubiquitins/antagonists & inhibitors , Ubiquitins/metabolism
4.
Chem Sci ; 6(1): 442-449, 2015 Jan 01.
Article in English | MEDLINE | ID: mdl-25530835

ABSTRACT

Lysine is a ubiquitous residue on protein surfaces. Post translational modifications of lysine, including methylation to the mono-, di- or trimethylated amine result in chemical and structural alterations that have major consequences for protein interactions and signalling pathways. Small molecules that bind to methylated lysines are potential tools to modify such pathways. To make progress in this direction, detailed structural data of ligands in complex with methylated lysine is required. Here, we report a crystal structure of p-sulfonatocalix[4]arene (sclx4) bound to methylated lysozyme in which the lysine residues were chemically modified from Lys-NH3+ to Lys-NH(Me2)+. Of the six possible dimethyllysine sites, sclx4 selected Lys116-Me2 and the dimethylamino substituent was deeply buried in the calixarene cavity. This complex confirms the tendency for Lys-Me2 residues to form cation-π interactions, which have been shown to be important in protein recognition of histone tails bearing methylated lysines. Supporting data from NMR spectroscopy and MD simulations confirm the selectivity for Lys116-Me2 in solution. The structure presented here may serve as a stepping stone to the development of new biochemical reagents that target methylated lysines.

5.
BMC Struct Biol ; 12: 16, 2012 Jul 02.
Article in English | MEDLINE | ID: mdl-22747601

ABSTRACT

BACKGROUND: S100 proteins are a family of small, EF-hand containing calcium-binding signaling proteins that are implicated in many cancers. While the majority of human S100 proteins share 25-65% sequence similarity, S100A7 and its recently identified paralog, S100A15, display 93% sequence identity. Intriguingly, however, S100A7 and S100A15 serve distinct roles in inflammatory skin disease; S100A7 signals through the receptor for advanced glycation products (RAGE) in a zinc-dependent manner, while S100A15 signals through a yet unidentified G-protein coupled receptor in a zinc-independent manner. Of the seven divergent residues that differentiate S100A7 and S100A15, four cluster in a zinc-binding region and the remaining three localize to a predicted receptor-binding surface. RESULTS: To investigate the structural and functional consequences of these divergent clusters, we report the X-ray crystal structures of S100A15 and S100A7D24G, a hybrid variant where the zinc ligand Asp24 of S100A7 has been substituted with the glycine of S100A15, to 1.7 Å and 1.6 Å resolution, respectively. Remarkably, despite replacement of the Asp ligand, zinc binding is retained at the S100A15 dimer interface with distorted tetrahedral geometry and a chloride ion serving as an exogenous fourth ligand. Zinc binding was confirmed using anomalous difference maps and solution binding studies that revealed similar affinities of zinc for S100A15 and S100A7. Additionally, the predicted receptor-binding surface on S100A7 is substantially more basic in S100A15 without incurring structural rearrangement. CONCLUSIONS: Here we demonstrate that S100A15 retains the ability to coordinate zinc through incorporation of an exogenous ligand resulting in a unique zinc-binding site among S100 proteins. The altered surface chemistry between S100A7 and S100A15 that localizes to the predicted receptor binding site is likely responsible for the differential recognition of distinct protein targets. Collectively, these data provide novel insight into the structural and functional consequences of the divergent surfaces between S100A7 and S100A15 that may be exploited for targeted therapies.


Subject(s)
Receptors, Cell Surface/metabolism , S100 Proteins/chemistry , S100 Proteins/metabolism , Zinc/metabolism , Amino Acid Sequence , Amino Acid Substitution/genetics , Binding Sites , COP9 Signalosome Complex , Crystallography, X-Ray , Humans , Intracellular Signaling Peptides and Proteins/metabolism , Models, Molecular , Molecular Sequence Data , Peptide Hydrolases/metabolism , Protein Binding , Receptor for Advanced Glycation End Products , Receptors, Immunologic/metabolism , S100 Calcium Binding Protein A7 , Surface Properties
6.
Org Biomol Chem ; 10(34): 6885-92, 2012 Sep 14.
Article in English | MEDLINE | ID: mdl-22828995

ABSTRACT

The binding of a series of indole-derived hosts to various ammonium cations in pure, buffered water is investigated using both solution phase (1)H NMR studies and computational modeling. These hosts can engage their targets via the cation-pi interaction, electrostatic attraction, and the hydrophobic effect. The hydrophobic effect is shown to be a dominant influence in the strength of the binding interactions, both in terms of the hydrophobicity of the host and of the guest. Our findings show that small changes that reduce the host hydrophobic surface area without reducing either the number of negative charges or amount of aromatic surface area are found to significantly decrease binding. Additionally, the position of solubilizing charges is also shown to influence the preferred host geometry and resulting binding constants.


Subject(s)
Indoles/chemistry , Lysine/analogs & derivatives , Water/chemistry , Lysine/chemistry , Models, Molecular , Molecular Conformation , Propionates/chemistry , Solutions , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...